Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Transatlantic Partners to Collaborate on Ready-to-Use Products for Microbiological Diagnostics

By LabMedica International staff writers
Posted on 28 Oct 2013
A recently announced transatlantic partnership is dedicated to developing, manufacturing, and marketing ready-to-use media products for microbiological diagnostics and research applications.

The French/German company Sartorius Stedim Biotech (Aubagne, France) - a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry - and BD Diagnostics (Franklin Lakes, NJ, USA), a leading global medical technology company, recently announced the formation of a collaborative effort to develop, manufacture, and market various ready-to-use, prefilled media products for detection and diagnosis of microorganisms in clinical and research laboratories. More...


Sartorius Stedim Biotech manufactures high quality, single-use filter products for concentration of microbial contaminants, and as part of this partnership agreement, BD Diagnostics will fill special Sartorius single-use products with BD's culture media and supply these back to Sartorius as prepackaged products.

In addition, the companies will be exploring options for extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics.

“Through our agreement with BD, we have created an excellent collaboration. BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD’s expertise combined with Sartorius Stedim Biotech’s know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring,” said Dominique Baly, member of the Sartorius group executive committee.

“The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech, and research customers with these unique product offerings,” said Bob Ferguson, vice president and general manager of BD Diagnostics. “By combining Sartorius Stedim Biotech’s bioprocessing and filtration expertise with BD’s microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing.”

Related Links:
Sartorius Stedim Biotech
BD Diagnostics 



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.